,0
0,DaVita Inc. Schedules 3rd Quarter 2023 Investor Conference Call
1,Is DaVita (DVA) Too Good to Be True? A Comprehensive Analysis of a Potential Value Trap
2,PetMeds (PETS) to Advance Pet Care With New Collaboration
3,Here's Why You Should Invest in Insulet (PODD) Stock for Now
4,Alcon (ALC) Stock Up 9.7% YTD: Will the Rally Continue?
5,Teleflex (TFX) Advances Urology Portfolio With New Buyout
6,UPDATE 1-Fresenius Medical: effect of drugs like Ozempic on patient numbers is neutral
7,"Walgreens Boots (WBA) Q4 Earnings Miss Estimates, Margins Down"
8,Here's Why You Should Hold on to Penumbra (PEN) Stock for Now
9,UPDATE 2-DaVita sees limited impact from Ozempic's kidney trial success
